| Maine Veterans Home - Augusta | |
| 310 Cony Road, Augusta, Maine 04330 | |
| (207) 622-2454 | |
| Name | Maine Veterans Home - Augusta |
|---|---|
| Location | 310 Cony Road, Augusta, Maine |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 65.58% |
| Medicare ID (CCN) | 205126 |
| Legal Business Name | Maine Veterans' Homes |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1942274766 |
| Organization Name | MAINE VETERANS' HOME |
| Doing Business As | MAINE VETERANS' HOMES |
| Address | 310 Cony Rd, Augusta, ME 04330 |
| Phone Number | 207-622-2454 |
News Archive
Scientists at the Texas Biomedical Research Institute have for the first time demonstrated that baboon embryonic stem cells can be programmed to completely restore a severely damaged artery. These early results show promise for eventually developing stem cell therapies to restore human tissues or organs damaged by age or disease.
Duke Medicine researchers have identified biochemical changes in people taking antidepressants - but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes.
Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
Reuters reports that states are cutting birth control subsidies while The Associated Press writes that it's difficult to gauge what impact anti-abortion laws have on reducing the procedure. The Arizona House gave initial approval to blocking abortion providers from getting federal funding for family planning services through the state. A similar move in Texas, which is now in effect, reverberates.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Scientists at the Texas Biomedical Research Institute have for the first time demonstrated that baboon embryonic stem cells can be programmed to completely restore a severely damaged artery. These early results show promise for eventually developing stem cell therapies to restore human tissues or organs damaged by age or disease.
Duke Medicine researchers have identified biochemical changes in people taking antidepressants - but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes.
Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
Reuters reports that states are cutting birth control subsidies while The Associated Press writes that it's difficult to gauge what impact anti-abortion laws have on reducing the procedure. The Arizona House gave initial approval to blocking abortion providers from getting federal funding for family planning services through the state. A similar move in Texas, which is now in effect, reverberates.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.15 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.57 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.46 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.14 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.4 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.15 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.48 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 7.46 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 22.52 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.89 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.51 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.15 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.96 | 82.93 |
News Archive
Scientists at the Texas Biomedical Research Institute have for the first time demonstrated that baboon embryonic stem cells can be programmed to completely restore a severely damaged artery. These early results show promise for eventually developing stem cell therapies to restore human tissues or organs damaged by age or disease.
Duke Medicine researchers have identified biochemical changes in people taking antidepressants - but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes.
Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
Reuters reports that states are cutting birth control subsidies while The Associated Press writes that it's difficult to gauge what impact anti-abortion laws have on reducing the procedure. The Arizona House gave initial approval to blocking abortion providers from getting federal funding for family planning services through the state. A similar move in Texas, which is now in effect, reverberates.
› Verified 3 days ago
Mainegeneral Rehab & Long Term Care - Gray Birch Location: 37 Gray Birch Drive, Augusta, Maine 04330 Phone: (207) 621-7100 | |
Augusta Center For Health & Rehabilitation, Llc Location: 188 Eastern Ave, Augusta, Maine 04330 Phone: (207) 622-3121 | |
Mainegeneral Rehab & Long Term Care - Glenridge Location: 40 Glenridge Drive, Augusta, Maine 04330 Phone: (207) 626-2600 |